DRAIC could inhibit the progression of prostate cancer (Saha et al., 2020) and gastric cancer (Zhang Z. et al., 2020), facilitate the proliferation and migration of nasopharyngeal carcinoma (Liao et al., 2019) and regulate autophagic flux (Tiessen et al., 2019). This evidence concerns the gene DRAIC and prostate cancer.